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From February to October 2003, Mycobacterium
goodii wound infections were identified among three
patients who received surgical implants at a Colorado  hos-
pital. This report summarizes the investigation of the first
reported nosocomial outbreak of M. goodii. Increased
awareness is needed about the potential for nontuberculous
mycobacteria to cause postoperative wound infections.
M
ycobacterium goodii is a recently identified, rapidly
growing nontuberculous mycobacteria species of the
M. smegmatis group (1). Previously associated with spo-
radic cases of cellulitis, osteomyelitis, infected pacemaker
sites, lipoid pneumonia (1,2), and bursitis (3), M. goodii
has not been associated with outbreaks.
The Study
In June 2003, staff at hospital A contacted the Centers
for Disease Control and Prevention (CDC) and the
Colorado Department of Public Health and Environment
(CDPHE) about two patients (patients 2 and 3) in whom
M. goodii wound infections developed after surgery at hos-
pital A. In October 2003, patient 1 notified CDPHE that he
had a M. goodii wound infection; he had previously under-
gone surgery at hospital A. 
Patient 1
A64-year-old man underwent left total hip arthroplasty
at hospital A in April 2002. In May 2003, he was evaluat-
ed at hospital A for chronic left hip pain. Bone scan sug-
gested prosthesis loosening or infection. Gram stain and
bacterial culture of aspirated joint fluid were negative.
Mycobacterial culture was not performed. 
In July 2003, he underwent arthroplasty revision at hos-
pital B for persistent pain. A preoperative sedimentation
rate was normal, but a substantial amount of yellow fluid
was noted during operative manipulation of the
trochanteric bursa. Fluid Gram stain demonstrated a mod-
erate number of leukocytes without organisms; bacterial
culture was negative, and mycobacterial culture was not
performed. 
Wound erythema with drainage developed 4 weeks
later, and septic hip arthritis was diagnosed at hospital B,
requiring prosthesis removal. Joint fluid, decontaminated
with Sputagest 50 mucolytic agent (Remel, Lenexa, KS),
grew mycobacteria after 7 days of incubation at 36°C with
Middlebrook 7H12 TB media (Becton Dickinson, Sparks,
MD) and Lowenstein-Jensen agar. Resulting colonies were
smooth, flat, mucoid, brownish-orange and later identified
as M. goodii sensitive to ciprofloxacin (MIC= 1 µg/mL),
doxycycline (MIC < 0.5 µg/mL), and trimethoprim/sul-
famethoxazole (MIC= 1 µg/mL). 
Patient 2
A 64-year-old man underwent right inguinal hernia
repair with a Kugel patch at hospital Ain January 2003. On
postoperative day 17, he underwent elective L3–L4
laminectomy at hospital C. Right inguinal pain, swelling,
and erythema developed 2 days later, and he required
wound debridement and patch removal. Patch cultures
grew mycobacteria after 3 days of incubation at 35°C with
sheep blood agar and thioglycolate broth without pretreat-
ment. The isolate was later identified as M. goodii sensi-
tive to ciprofloxacin (MIC = 0.25 µg/mL), doxycycline
(MIC < 0.5 µg/mL), and trimethoprim/sulfamethoxazole
(MIC = 2 µg/mL). 
Patient 3
A woman 75 years of age underwent a total replace-
ment of her left knee at hospital A in April 2003. On post-
operative day 14, pain and swelling developed in her left
knee. Fluid aspirated from the wound on postoperative day
29 was negative by Gram stain and bacterial culture.
Mycobacterial culture was not performed, and antimicro-
bial drugs were withheld. Repeat Gram stain 9 days later
demonstrated many leukocytes without organisms. The
prosthesis was later removed and replaced with a stabiliz-
ing polyethylene insert. Wound drainage samples, decon-
taminated with N-acetyl-L-cysteine-sodium hydroxide,
grew mycobacteria after 11 days of incubation at 37°C
with BacT/ALERT media (bioMérieux, Durham, NC) and
Lowenstein-Jensen agar. The isolate was later identified as
M. goodii sensitive to ciprofloxacin (MIC = 0.25 µg/mL),
doxycycline (MIC < 0.5 µg/mL), and trimethoprim/sul-
famethoxazole (MIC = 4 µg/mL). 
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shock protein gene polymerase chain reaction restriction
analysis, by using enzymes BstEII,  HaeIII,  BsaHI, and
AciI (New England Biolabs, Beverly, MA) and matching
them to a control strain, M. goodii ATCC 700504 (1).
Susceptibilities were assessed according to the NCCLS
document M24-A (4). Isolates were grown and compared
by pulsed-field gel electrophoresis (PFGE) according to
previously described methods (5). Genomic DNA restric-
tion was performed with 40 U of AseI (New England
Biolabs, Beverly, MA). Less than a three-band difference
was found among the resulting patterns (Figure). Based on
previously described criteria (6), these isolates were close-
ly related and probably from the same source.
Anesthesiologist A was the only person who had con-
tact with all three patients during an operative procedure
(Table). Anesthesiologist A was also present during an
operation on a potential case-patient in whom an inguinal
wound infection developed 29 days after his hernia had
been repaired with a Kugel patch at hospital A in January
2003. Although mycobacterial cultures were not per-
formed, a Gram stain of drainage material showed many
leukocytes without organisms, and bacterial cultures were
negative. This patient improved after surgical drainage,
patch removal, and treatment with cephalexin. No other
potential cases were identified retrospectively through
questioning of surgical staff or prospectively with active
surveillance.
Anesthesiologist A was assessed for M. goodii carriage
by collecting a sputum sample, beard clippings, and sam-
pling his nares and operating shoes with sterile swabs.
Swabs were placed in Butterfield buffer (Becton
Dickinson, Cockeysville, MD), exposed to 0.005%
cetylpyridinium chloride monohydrate, vortexed, concen-
trated, added to 7H10 agar plates, and incubated at 35°C
and 30°C for 14 days. Hand screening was also performed
by using sterile premoistened wipes to wipe both hands
and each finger. Wipes were processed and cultured simi-
lar to the procedure described above for swabs. All speci-
mens from anesthesiologist A were negative.
Specimens from hands and operating room shoes were
also collected from 12 staff members present in operating
rooms before or during any of the three patients’ proce-
dures. All of these specimens were negative. 
Water was tested by using sterile swabs to sample
biofilm and water from faucets in the operating room area,
including the scrub, sterile supply, and clean and dirty util-
ity room sinks. Sterile swabs were also used to sample
lights, vents, and anesthesia tables in the operating rooms,
equipment sterilizers, and rubber floor mats adjacent to
scrub sinks. All environmental samples were negative. No
environmental breaches were found in the sterile supply
area, including no evidence of water damage, and no
recent construction.
Two patients received local anesthesia from single dose
vials during surgery. Alcohol and povidone-iodine were
used for skin preparation before all three procedures, and
quaternary ammonium was used to disinfect operating
rooms at hospital A. Clinical laboratories in Colorado were
contacted, and no other M. goodii cases were identified in
Colorado from 2002 to 2003. 
Conclusions
Although this cluster occurred over an extensive peri-
od, it likely had a common etiology because M. goodii has
been infrequently identified as a pathogen, and isolates had
closely-related PFGE patterns. PFGE has been reported as
a means of identifying outbreaks of other nontuberculous
mycobacteria, including M. fortuitum (5),  M. chelonae,
and M. abscessus (7).
Additionally, all patients received surgical implants at
the same hospital before their infections. Although patient
1 had arthroplasty revision at another hospital 1 month
before diagnosis, chronic hip pain, an abnormal bone scan
before revision, and an abnormal amount of bursal fluid
during surgery suggest that he had indolent infection that
preceded the second hip surgery. 
Anesthesiologist A seemed a possible infection source
because he was the only person present during each surgery
at hospital A. Unscrubbed surgical personnel have been
linked to other postoperative wound infections, including
an anesthesiologist colonized with Nocardia farcinica who
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Figure. Pulsed-field gel electrophoresis patterns using restriction
enzyme AseI, of Mycobacterium goodii isolates from three patients
with postoperative wound infections after receiving surgical
implants from a hospital in Colorado. Lane 1 is control strain M.
goodii ATCC 700504. Lanes 2–4 are case-isolates. Lane 5 is a
48.5-kb DNA marker. reportedly caused five postoperative sternotomy infections
(8). Although our investigation did not identify anesthesiol-
ogist Aas an M. goodii carrier, carriage status was assessed
months after the outbreak, and transient carriage is possi-
ble. Additionally, we were unable to identify published
methods on how to assess M. goodii carriage.
M. goodii was not isolated from hospital A’s water sup-
ply, based on swabs of biofilm and water from sinks, but
other outbreaks of nontuberculous mycobacteria infections
have been linked to municipal water (9). In one study, 95
(83%) of 115 dialysis centers had nontuberculous
mycobacteria in their water supply (10). Many nontuber-
culous mycobacteria grow in biofilms that can form at
faucet outlets, and several grow in hot, chlorinated, and
distilled water (9). Although M. goodii was not isolated
from any sink or water specimens, a water source could
not definitively be ruled out. The hospital superheats the
water system annually to 87.2°C (last done 1 month before
this investigation) but does not culture water specimens.
Therefore, water flora at the time of these infections could
have been different from the flora present during the inves-
tigation. Additionally, because water specimens were col-
lected with swabs rather than through a bulk water
collection,  M. goodii contamination might have been
missed if concentrations were sufficiently low.
Although multidose vials were not linked to this out-
break, they caused other nontuberculous mycobacteria out-
breaks (9,11). Several nontuberculous mycobacteria are
resistant to mercury, which is commonly used as a preser-
vative in multidose vials (9). 
Nontuberculous mycobacteria are relatively resistant to
disinfectants (9), and disinfectant and antiseptic effective-
ness against M. goodii have not been reported. M. smeg-
matis, which is closely related to M. goodii, is sensitive to
alkaline glutaraldehyde (12,13), povidone iodine (13,14),
and chlorhexidene gluconate disinfectants. Sodium
hypochlorite, ethanol, phenol, and quaternary ammonium
are less effective (13).
M. goodii is generally susceptible to amikacin, ethamb-
utol, and sulfamethoxazole. It has intermediate susceptibil-
ity to ciprofloxacin, doxycycline, and tobramycin; variable
susceptibility to cefmetazole, cefoxitin, and clar-
ithromycin; and resistance to isoniazid and rifampin (1).
For mild wound infections, monotherapy with an oral
agent for 4–6 months has been effective. In more severe
disease, surgical debridement, initial combination therapy,
followed by oral therapy, to complete 6 months of treat-
ment has been effective (2).
The lack of an identified infection source made
focused control measures difficult. Measures implement-
ed by hospital A included requiring single-dose medica-
tion vials for invasive procedures; culturing for
mycobacteria in wound cultures with negative bacterial
growth; requiring staff to cover scrubs and remove shoe
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and hair covers when leaving the operating room area and
to apply new covers upon reentering; requiring staff to use
dedicated shoes in the operating room; having patients
take preoperative showers with antiseptic soap; using
tobramycin-impregnated cement in appropriate proce-
dures; avoiding flash sterilization of implantable devices;
and using phenol disinfectant weekly and quaternary
ammonium disinfectant daily to disinfect operating
rooms. Although data for M. smegmatis suggest that phe-
nol and quaternary ammonium disinfectants might not be
effective against M. goodii (13), evidence is insufficient to
make firm recommendations. 
Patients 2 and 3 received a diagnosis relatively quickly,
but patient 1 had a prolonged, indolent infection and had
an arthroplasty revision before diagnosis. Several wound
cultures were performed without assessment for mycobac-
terial infection. Although documented (9), nontuberculous
mycobacteria wound infections are less common than bac-
terial infections, and clinicians might be less aware of non-
tuberculous mycobacteria as potential causes of surgical
site infections. 
Research is needed to determine effective antiseptics
and disinfectants against M. goodii. Clinicians should be
aware of the association of nontuberculous mycobacteria
with surgical site infections and consider testing for
mycobacteria when a Gram stain shows notable numbers of
leukocytes, but wound cultures are negative for bacteria.
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